Rosecliff Acquisition Corp. I: Spectral MD Holdings, Ltd., a

Rosecliff Acquisition Corp. I: Spectral MD Holdings, Ltd., an FDA Breakthrough Designated company focused on Artificial Intelligence driven Medical Diagnostic Solutions, to be Listed on Nasdaq Through Business Combination with Rosecliff Acquisition Corp I

Spectral MD is an Artificial Intelligence (AI) company focused on predictive medical diagnostics. The Company's FDA Breakthrough Designated DeepView AI Wound Diagnostics platform ("DeepView") uses

Related Keywords

Dallas , Texas , United States , London , City Of , United Kingdom , Devin Sullivan , Vince Capone , Stuart Gledhill Harry Davies , Mike Murphy , Vadim Alexandre Rob Rees , Ghost Merger Sub , Deepview Ai Wound Diagnostics Technology , Equity Group Inc , Company Deepview , Nasdaq , Rosecliff Acquisition Corp , Sp Angel Corporate Finance , Meagher Flom , Spectral Md Holdings Ltd , Nasdaq The Combined Company , Ghost Merger Subi Inc , Rosecliff Acquisition Corpi , Company Board , Ai Wound Diagnostics Technology , Reed Smith , Dtrs Of The Financial Conduct Authority , Exchange Commission , London Stock Exchange The Delisting , Artificial Intelligence , Designated Deepview , Combined Company , Chief Executive Officer Wensheng Fan , Diagnostics Technology , Chief Executive Officer , Diagnostics Platform , Clinical Applications , Proven Leadership , Sources Sought Notice , London Stock Exchange , Corporate Finance , Wound Diagnostics , Registration Statement , Securities Act , Private Securities Litigation Reform Act , Nasdaq Capital Market , Annual Report , Quarterly Reports , Disclosure Guidance , Transparency Rules , Financial Conduct Authority , Joint Broker , Gledhill Harry Davies Ball , Alexandre Rob Rees , Sales Broking , Equity Group , United Kingdom Media Investor Relations , Mcmanus Louis Ashe Jepson Alice Woodings , Rosecliff , Cquisition , Orp , Spectral , Oldings , Breakthrough , Esignated , Company , Ocused , Rtificial , Intelligence , Riven , Medical , Iagnostic , Solutions , Isted , Through , Business , Acombi ,

© 2025 Vimarsana